Sarepta Therapeutics SRPT
NASDAQ SRPT
$16.68 +0.26 (+1.58%)
As of: Nov 11, 2026 · 3:52 PM EST

Sarepta Therapeutics (SRPT) Return on Equity [ROE] (2009 - 2026)

Updated

Sarepta Therapeutics (SRPT) recorded Return on Equity [ROE] of -9.02% in Q2 2026, down 4.55 percentage points from -4.46% a year earlier and down 13.94 percentage points from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, Sarepta Therapeutics reported Return on Equity [ROE] of -53.47%, down 73.18 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a five-year change of +16.67 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at 19.71% in FY2024 (+105.86 pp), -86.15% in FY2023 (+21.01 pp), -107.16% in FY2022 (-57.59 pp) and -49.57% in FY2021 (+20.58 pp).
  • Quarterly Return on Equity [ROE] has ranged from -203.19% in Q1 2023 to 17.12% in Q4 2024 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] rose in three of the last eight quarters, with an average year-over-year change of +8.66 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 205.04 percentage points in Q1 2024, against a drop of 163.24 percentage points in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at 4.92% (Q1 2026), -57.98% (Q4 2025) and -19.93% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Sarepta Therapeutics 1.76 Bn -1.50 Bn 192.84 Mn -7.59%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -7.59%
Jun 30, 2026 -9.02%
Mar 31, 2026 4.94%
Dec 31, 2025 -54.06%
Sep 30, 2025 -9.94%
Jun 30, 2025 -4.39%
Mar 31, 2025 -18.20%
Dec 31, 2024 17.06%
Sep 30, 2024 10.88%
Jun 30, 2024 4.68%
Mar 31, 2024 1.83%
Dec 31, 2023 -65.70%
Sep 30, 2023 -91.42%
Jun 30, 2023 -124.64%
Mar 31, 2023 -203.21%
Dec 31, 2022 -172.87%
Sep 30, 2022 -124.33%
Jun 30, 2022 -64.31%
Mar 31, 2022 -39.99%
Dec 31, 2021 -59.93%
API Access

Sarepta Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SRPT&period=max&api_key=YOUR_API_KEY